This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Sep 10;30(26):3162-4.

doi: 10.1200/JCO.2012.42.9738. Epub 2012 Aug 6.

Making advances in first-line chronic lymphocytic leukemia treatment

William G Wierda

PMID: 22869876
DOI: 10.1200/JCO.2012.42.9738

Editorial

Making advances in first-line chronic lymphocytic leukemia treatment

William G Wierda. J Clin Oncol. 2012.

. 2012 Sep 10;30(26):3162-4.

doi: 10.1200/JCO.2012.42.9738. Epub 2012 Aug 6.

Author

William G Wierda

PMID: 22869876
DOI: 10.1200/JCO.2012.42.9738

No abstract available

PubMed Disclaimer

Comment on

Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.
Fischer K, Cramer P, Busch R, Böttcher S, Bahlo J, Schubert J, Pflüger KH, Schott S, Goede V, Isfort S, von Tresckow J, Fink AM, Bühler A, Winkler D, Kreuzer KA, Staib P, Ritgen M, Kneba M, Döhner H, Eichhorst BF, Hallek M, Stilgenbauer S, Wendtner CM. Fischer K, et al. J Clin Oncol. 2012 Sep 10;30(26):3209-16. doi: 10.1200/JCO.2011.39.2688. Epub 2012 Aug 6. J Clin Oncol. 2012. PMID: 22869884 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.